Richard Price - Publications

Affiliations: 
UCSF School of Medicine UCSF School of Medicine 
Area:
Neuro HIV, AIDS dementia complex

109 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Ferretti F, Gisslen M, Cinque P, Price RW. Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy. Current Hiv/Aids Reports. 12: 280-8. PMID 25860317 DOI: 10.1007/s11904-015-0267-7  1
2015 Sturdevant CB, Joseph SB, Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection. Plos Pathogens. 11: e1004720. PMID 25811757 DOI: 10.1371/journal.ppat.1004720  1
2015 Wright PW, Vaida FF, Fernández RJ, Rutlin J, Price RW, Lee E, Peterson J, Fuchs D, Shimony JS, Robertson KR, Walter R, Meyerhoff DJ, Spudich S, Ances BM. Cerebral white matter integrity during primary HIV infection. Aids (London, England). 29: 433-42. PMID 25513818 DOI: 10.1097/QAD.0000000000000560  1
2014 Peterson J, Gisslen M, Zetterberg H, Fuchs D, Shacklett BL, Hagberg L, Yiannoutsos CT, Spudich SS, Price RW. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection. Plos One. 9: e116081. PMID 25541953 DOI: 10.1371/journal.pone.0116081  1
2014 Suh J, Sinclair E, Peterson J, Lee E, Kyriakides TC, Li FY, Hagberg L, Fuchs D, Price RW, Gisslen M, Spudich S. Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection. Journal of Neuroinflammation. 11: 199. PMID 25465205 DOI: 10.1186/s12974-014-0199-y  1
2014 Young AC, Yiannoutsos CT, Hegde M, Lee E, Peterson J, Walter R, Price RW, Meyerhoff DJ, Spudich S. Cerebral metabolite changes prior to and after antiretroviral therapy in primary HIV infection. Neurology. 83: 1592-600. PMID 25261502 DOI: 10.1212/WNL.0000000000000932  1
2014 Chow FC, Bacchetti P, Kim AS, Price RW, Hsue PY. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection. Aids (London, England). 28: 2573-7. PMID 25160935 DOI: 10.1097/QAD.0000000000000452  1
2014 Dahl V, Peterson J, Fuchs D, Gisslen M, Palmer S, Price RW. Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation. Aids (London, England). 28: 2251-8. PMID 25022595 DOI: 10.1097/QAD.0000000000000400  1
2014 Grill MF, Price RW. Central nervous system HIV-1 infection. Handbook of Clinical Neurology. 123: 487-505. PMID 25015501 DOI: 10.1016/B978-0-444-53488-0.00023-7  1
2014 Wang SX, Ho EL, Grill M, Lee E, Peterson J, Robertson K, Fuchs D, Sinclair E, Price RW, Spudich S. Peripheral neuropathy in primary HIV infection associates with systemic and central nervous system immune activation. Journal of Acquired Immune Deficiency Syndromes (1999). 66: 303-10. PMID 24732871 DOI: 10.1097/QAI.0000000000000167  1
2014 Price RW, Spudich SS, Peterson J, Joseph S, Fuchs D, Zetterberg H, Gisslén M, Swanstrom R. Evolving character of chronic central nervous system HIV infection. Seminars in Neurology. 34: 7-13. PMID 24715483 DOI: 10.1055/s-0034-1372337  1
2014 Jessen Krut J, Mellberg T, Price RW, Hagberg L, Fuchs D, Rosengren L, Nilsson S, Zetterberg H, Gisslén M. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients. Plos One. 9: e88591. PMID 24523921 DOI: 10.1371/journal.pone.0088591  1
2014 Gold JA, Grill M, Peterson J, Pilcher C, Lee E, Hecht FM, Fuchs D, Yiannoutsos CT, Price RW, Robertson K, Spudich S. Longitudinal characterization of depression and mood states beginning in primary HIV infection. Aids and Behavior. 18: 1124-32. PMID 24385231 DOI: 10.1007/s10461-013-0688-5  1
2014 Dahl V, Gisslen M, Hagberg L, Peterson J, Shao W, Spudich S, Price RW, Palmer S. An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy. The Journal of Infectious Diseases. 209: 1618-22. PMID 24338353 DOI: 10.1093/infdis/jit805  1
2013 Meyer AC, Boscardin WJ, Kwasa JK, Price RW. Is it time to rethink how neuropsychological tests are used to diagnose mild forms of HIV-associated neurocognitive disorders? Impact of false-positive rates on prevalence and power. Neuroepidemiology. 41: 208-16. PMID 24157541 DOI: 10.1159/000354629  1
2013 Cettomai D, Kwasa JK, Birbeck GL, Price RW, Cohen CR, Bukusi EA, Kendi C, Meyer AC. Screening for HIV-associated peripheral neuropathy in resource-limited settings. Muscle & Nerve. 48: 516-24. PMID 24037693 DOI: 10.1002/mus.23795  1
2013 Grund B, Wright EJ, Brew BJ, Price RW, Roediger MP, Bain MP, Hoy JF, Shlay JC, Vjecha MJ, Robertson KR. Improved neurocognitive test performance in both arms of the SMART study: impact of practice effect. Journal of Neurovirology. 19: 383-92. PMID 23943468 DOI: 10.1007/s13365-013-0190-x  1
2013 Price RW, Peterson J, Fuchs D, Angel TE, Zetterberg H, Hagberg L, Spudich S, Smith RD, Jacobs JM, Brown JN, Gisslen M. Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 1147-58. PMID 23943280 DOI: 10.1007/s11481-013-9491-3  1
2013 Ho EL, Ronquillo R, Altmeppen H, Spudich SS, Price RW, Sinclair E. Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects. Plos One. 8: e66188. PMID 23822975 DOI: 10.1371/journal.pone.0066188  1
2013 Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, ... ... Price RW, et al. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. Plos Pathogens. 9: e1003347. PMID 23671416 DOI: 10.1371/journal.ppat.1003347  1
2013 Yilmaz A, Yiannoutsos CT, Fuchs D, Price RW, Crozier K, Hagberg L, Spudich S, Gisslén M. Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy. Journal of Neuroinflammation. 10: 62. PMID 23664008 DOI: 10.1186/1742-2094-10-62  1
2013 Peluso MJ, Meyerhoff DJ, Price RW, Peterson J, Lee E, Young AC, Walter R, Fuchs D, Brew BJ, Cinque P, Robertson K, Hagberg L, Zetterberg H, Gisslén M, Spudich S. Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection. The Journal of Infectious Diseases. 207: 1703-12. PMID 23460748 DOI: 10.1093/infdis/jit088  1
2013 Dahl V, Peterson J, Spudich S, Lee E, Shacklett BL, Price RW, Palmer S. Single-copy assay quantification of HIV-1 RNA in paired cerebrospinal fluid and plasma samples from elite controllers. Aids (London, England). 27: 1145-9. PMID 23211774 DOI: 10.1097/QAD.0b013e32835cf235  1
2013 Krut JJ, Zetterberg H, Blennow K, Cinque P, Hagberg L, Price RW, Studahl M, Gisslén M. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. Journal of Neurology. 260: 620-6. PMID 23052602 DOI: 10.1007/s00415-012-6688-y  1
2012 Price RW, Swanstrom R. Targeting chronic central nervous system HIV infection. Antiviral Therapy. 17: 1227-31. PMID 23018178 DOI: 10.3851/IMP2414  1
2012 Fanara P, Wong PY, Husted KH, Liu S, Liu VM, Kohlstaedt LA, Riiff T, Protasio JC, Boban D, Killion S, Killian M, Epling L, Sinclair E, Peterson J, Price RW, et al. Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. The Journal of Clinical Investigation. 122: 3159-69. PMID 22922254 DOI: 10.1172/JCI64575  1
2012 Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 868-76. PMID 22661489 DOI: 10.1093/cid/cis507  1
2012 Peluso MJ, Ferretti F, Peterson J, Lee E, Fuchs D, Boschini A, Gisslén M, Angoff N, Price RW, Cinque P, Spudich S. Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load. Aids (London, England). 26: 1765-74. PMID 22614889 DOI: 10.1097/QAD.0b013e328355e6b2  1
2012 Angel TE, Jacobs JM, Spudich SS, Gritsenko MA, Fuchs D, Liegler T, Zetterberg H, Camp DG, Price RW, Smith RD. The cerebrospinal fluid proteome in HIV infection: change associated with disease severity. Clinical Proteomics. 9: 3. PMID 22433316 DOI: 10.1186/1559-0275-9-3  1
2012 Kwasa J, Cettomai D, Lwanya E, Osiemo D, Oyaro P, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Lessons learned developing a diagnostic tool for HIV-associated dementia feasible to implement in resource-limited settings: pilot testing in Kenya. Plos One. 7: e32898. PMID 22412945 DOI: 10.1371/journal.pone.0032898  1
2012 Yilmaz A, Price RW, Gisslén M. Antiretroviral drug treatment of CNS HIV-1 infection. The Journal of Antimicrobial Chemotherapy. 67: 299-311. PMID 22160207 DOI: 10.1093/jac/dkr492  1
2011 Gisslén M, Price RW, Nilsson S. The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence? Bmc Infectious Diseases. 11: 356. PMID 22204557 DOI: 10.1186/1471-2334-11-356  1
2011 Dahl V, Lee E, Peterson J, Spudich SS, Leppla I, Sinclair E, Fuchs D, Palmer S, Price RW. Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy. The Journal of Infectious Diseases. 204: 1936-45. PMID 22021620 DOI: 10.1093/infdis/jir667  1
2011 Schnell G, Joseph S, Spudich S, Price RW, Swanstrom R. HIV-1 replication in the central nervous system occurs in two distinct cell types. Plos Pathogens. 7: e1002286. PMID 22007152 DOI: 10.1371/journal.ppat.1002286  1
2011 Spudich S, Gisslen M, Hagberg L, Lee E, Liegler T, Brew B, Fuchs D, Tambussi G, Cinque P, Hecht FM, Price RW. Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden. The Journal of Infectious Diseases. 204: 753-60. PMID 21844301 DOI: 10.1093/infdis/jir387  1
2011 Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, et al. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. Journal of Neurovirology. 17: 438-47. PMID 21786076 DOI: 10.1007/s13365-011-0044-3  1
2011 Cettomai D, Kwasa J, Birbeck GL, Price RW, Bukusi EA, Meyer AC. Training needs and evaluation of a neuro-HIV training module for non-physician healthcare workers in western Kenya. Journal of the Neurological Sciences. 307: 92-6. PMID 21652049 DOI: 10.1016/j.jns.2011.05.005  1
2011 Ho EL, Spudich SS, Lee E, Fuchs D, Sinclair E, Price RW. Minocycline fails to modulate cerebrospinal fluid HIV infection or immune activation in chronic untreated HIV-1 infection: results of a pilot study. Aids Research and Therapy. 8: 17. PMID 21569420 DOI: 10.1186/1742-6405-8-17  1
2011 Price RW. Impact of antiretroviral therapy on HIV-related brain injury. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 52: 244-7. PMID 21288851 DOI: 10.1093/cid/ciq052  1
2011 Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M. Reply to Seligman Journal of Infectious Diseases. 204: 174-175. DOI: 10.1093/infdis/jir235  1
2010 Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA, Cohen CR, Meyer AC. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. Plos One. 5: e14256. PMID 21170387 DOI: 10.1371/journal.pone.0014256  1
2010 Edén A, Fuchs D, Hagberg L, Nilsson S, Spudich S, Svennerholm B, Price RW, Gisslén M. HIV-1 viral escape in cerebrospinal fluid of subjects on suppressive antiretroviral treatment Journal of Infectious Diseases. 202: 1819-1825. PMID 21050119 DOI: 10.1086/657342  1
2010 Lifson AR, Belloso WH, Davey RT, Duprez D, Gatell JM, Hoy JF, Krum EA, Nelson R, Pedersen C, Perez G, Price RW, Prineas RJ, Rhame FS, Sampson JH, et al. Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials. Hiv Clinical Trials. 11: 205-19. PMID 20974576 DOI: 10.1310/hct1104-205  1
2010 Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva De Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons Neurology. 75: 864-873. PMID 20702792 DOI: 10.1212/WNL.0b013e3181f11bd8  1
2010 Probasco JC, Deeks SG, Lee E, Hoh R, Hunt PW, Liegler T, Price RW, Spudich SS. Cerebrospinal fluid in HIV-1 systemic viral controllers: Absence of HIV-1 RNA and intrathecal inflammation Aids. 24: 1001-1005. PMID 20299968 DOI: 10.1097/QAD.0b013e328331e15b  1
2010 Tavel JA, Babiker A, Fox L, Gey D, Lopardo G, Markowitz N, Paton N, Wentworth D, Wyman N. Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study. Plos One. 5: e9334. PMID 20186278 DOI: 10.1371/journal.pone.0009334  1
2010 Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. Journal of Virology. 84: 2395-407. PMID 20015984 DOI: 10.1128/JVI.01863-09  1
2010 Hagberg L, Cinque P, Gisslen M, Brew BJ, Spudich S, Bestetti A, Price RW, Fuchs D. Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection Aids Research and Therapy. 7. DOI: 10.1186/1742-6405-7-15  1
2009 Gisslén M, Krut J, Andreasson U, Blennow K, Cinque P, Brew BJ, Spudich S, Hagberg L, Rosengren L, Price RW, Zetterberg H. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection Bmc Neurology. 9. PMID 20028512 DOI: 10.1186/1471-2377-9-63  1
2009 Cinque P, Koralnik IJ, Gerevini S, Miro JM, Price RW. Progressive multifocal leukoencephalopathy in HIV-1 infection The Lancet Infectious Diseases. 9: 625-636. PMID 19778765 DOI: 10.1016/S1473-3099(09)70226-9  1
2009 Yilmaz A, Gisslén M, Spudich S, Lee E, Jayewardene A, Aweeka F, Price RW. Raltegravir cerebrospinal fluid concentrations in HIV-1 infection Plos One. 4. PMID 19721718 DOI: 10.1371/journal.pone.0006877  1
2009 Harrington PR, Schnell G, Letendre SL, Ritola K, Robertson K, Hall C, Burch CL, Jabara CB, Moore DT, Ellis RJ, Price RW, Swanstrom R. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. Aids (London, England). 23: 907-15. PMID 19414991 DOI: 10.1097/QAD.0b013e3283299129  1
2009 Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. Plos Pathogens. 5: e1000395. PMID 19390619 DOI: 10.1371/journal.ppat.1000395  1
2009 Yilmaz A, Izadkhashti A, Price RW, Mallon PW, De Meulder M, Timmerman P, Gisslén M. Darunavir concentrations in cerebrospinal fluid and blood in HIV-1-infected individuals Aids Research and Human Retroviruses. 25: 457-461. PMID 19320601 DOI: 10.1089/aid.2008.0216  1
2009 Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. Journal of Virology. 83: 4068-80. PMID 19211740 DOI: 10.1128/JVI.02486-08  1
2009 Franciotta D, Bestetti A, Sala S, Perucca P, Jarius S, Price RW, Di Stefano AL, Cinque P. Broad screening for human herpesviridae DNA in multiple sclerosis cerebrospinal fluid and serum Acta Neurologica Belgica. 109: 277-282.  1
2008 Buescher JL, Duan F, Sun J, Price RW, Ikezu T. OTK18 levels in plasma and cerebrospinal fluid correlate with viral load and CD8 T-cells in normal and AIDS patients. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 230-5. PMID 18773297 DOI: 10.1007/s11481-008-9125-3  1
2008 Probasco JC, Spudich SS, Critchfield J, Lee E, Lollo N, Deeks SG, Price RW. Failure of atorvastatin to modulate CSF HIV-1 infection: Results of a pilot study Neurology. 71: 521-524. PMID 18695163 DOI: 10.1212/01.wnl.0000325006.84658.e7  1
2008 Price RW, Parham R, Kroll JL, Wring SA, Baker B, Sailstad J, Hoh R, Liegler T, Spudich S, Kuritzkes DR, Deeks SG. Enfuvirtide cerebrospinal fluid (CSF) pharmacokinetics and potential use in defining CSF HIV-1 origin Antiviral Therapy. 13: 369-374. PMID 18572749  1
2008 Lifson AR, Belloso WH, Carey C, Davey RT, Duprez D, El-Sadr WM, Gatell JM, Gey DC, Hoy JF, Krum EA, Nelson R, Nixon DE, Paton N, Pedersen C, ... ... Price RW, et al. Determination of the underlying cause of death in three multicenter international HIV clinical trials. Hiv Clinical Trials. 9: 177-85. PMID 18547904 DOI: 10.1310/hct0903-177  1
2008 Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection Journal of Infectious Diseases. 197: S294-S306. PMID 18447615 DOI: 10.1086/533419  1
2008 Sinclair E, Ronquillo R, Lollo N, Deeks SG, Hunt P, Yiannoutsos CT, Spudich S, Price RW. Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection. Journal of Acquired Immune Deficiency Syndromes (1999). 47: 544-52. PMID 18362693 DOI: 10.1097/QAI.0b013e318162754f  1
2008 Yilmaz A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes. 47: 168-173. PMID 17971711 DOI: 10.1097/QAI.0b013e31815ace97  1
2007 Edén A, Price RW, Spudich S, Fuchs D, Hagberg L, Gisslén M. Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy Journal of Infectious Diseases. 196: 1779-1783. PMID 18190258 DOI: 10.1086/523648  1
2007 Gisslen M, Hagberg L, Rosengren L, Brew BJ, Cinque P, Spudich S, Price RW. Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers Journal of Neuroimmune Pharmacology. 2: 112-119. PMID 18040834 DOI: 10.1007/s11481-006-9035-1  1
2007 Price RW, Epstein LG, Becker JT, Cinque P, Gisslen M, Pulliam L, McArthur JC. Biomarkers of HIV-1 CNS infection and injury. Neurology. 69: 1781-8. PMID 17967994 DOI: 10.1212/01.wnl.0000278457.55877.eb  1
2007 Mellgren A, Price RW, Hagberg L, Rosengren L, Brew BJ, Gisslén M. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection Neurology. 69: 1536-1541. PMID 17923616 DOI: 10.1212/01.wnl.0000277635.05973.55  1
2007 Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, ... ... Price RW, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 69: 1789-99. PMID 17914061 DOI: 10.1212/01.WNL.0000287431.88658.8b  1
2007 Paul RH, Yiannoutsos CT, Miller EN, Chang L, Marra CM, Schifitto G, Ernst T, Singer E, Richards T, Jarvik GJ, Price R, Meyerhoff DJ, Kolson D, Ellis RJ, Gonzalez G, et al. Proton MRS and neuropsychological correlates in AIDS dementia complex: evidence of subcortical specificity. The Journal of Neuropsychiatry and Clinical Neurosciences. 19: 283-92. PMID 17827413 DOI: 10.1176/appi.neuropsych.19.3.283  1
2007 Gisslén M, Hagberg L, Brew BJ, Cinque P, Price RW, Rosengren L. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex Journal of Infectious Diseases. 195: 1774-1778. PMID 17492593 DOI: 10.1086/518043  1
2007 Abdulle S, Mellgren A, Brew BJ, Cinque P, Hagberg L, Price RW, Rosengren L, Gisslén M. CSF neurofilament protein (NFL) - A marker of active HIV-related neurodegeneration Journal of Neurology. 254: 1026-1032. PMID 17420923 DOI: 10.1007/s00415-006-0481-8  1
2007 Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson H, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, Mc Arthur JC, Symonds W, et al. Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial. Plos Clinical Trials. 2: e13. PMID 17401456 DOI: 10.1371/journal.pctr.0020013  1
2007 Cinque P, Brew BJ, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid markers in central nervous system HIV infection and AIDS dementia complex Handbook of Clinical Neurology. 85: 261-300. DOI: 10.1016/S0072-9752(07)85017-2  1
2006 Price RW. Editorial comment: AIDS dementia complex in the current era Aids Reader. 16: 630-631. PMID 17152650  1
2006 Spudich S, Lollo N, Liegler T, Deeks SG, Price RW. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure Journal of Infectious Diseases. 194: 1686-1696. PMID 17109340 DOI: 10.1086/508750  1
2006 Hunt PW, Harrigan PR, Huang W, Bates M, Williamson DW, McCune JW, Price RW, Spudich SS, Lampiris H, Hoh R, Leigler T, Martin JN, Deeks SG. Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia Journal of Infectious Diseases. 194: 926-930. PMID 16960780 DOI: 10.1086/507312  1
2006 Robertson KR, Parsons TD, Sidtis JJ, Hanlon Inman T, Robertson WT, Hall CD, Price RW. Timed Gait test: normative data for the assessment of the AIDS dementia complex. Journal of Clinical and Experimental Neuropsychology. 28: 1053-64. PMID 16840235 DOI: 10.1080/13803390500205684  1
2005 Cinque P, Robertson K, Antinori A, Price RW. Neurological complications of HIV infection and AIDS: Current and future perspectives Journal of Neurovirology. 11: 1-5. PMID 16540446 DOI: 10.1080/13550280600558923  1
2005 Spudich SS, Nilsson AC, Lollo ND, Liegler TJ, Petropoulos CJ, Deeks SG, Paxinos EE, Price RW. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. Bmc Infectious Diseases. 5: 98. PMID 16266436 DOI: 10.1186/1471-2334-5-98  1
2005 Mellgren A, Antinori A, Cinque P, Price RW, Eggers C, Hagberg L, Gisslén M. Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment Antiviral Therapy. 10: 701-707. PMID 16218168  1
2005 Neuenburg JK, Furlan S, Bacchetti P, Price RW, Grant RM. Enrichment of activated monocytes in cerebrospinal fluid during antiretroviral therapy Aids. 19: 1351-1359. PMID 16103765  1
2005 Cinque P, Bestetti A, Marenzi R, Sala S, Gisslen M, Hagberg L, Price RW. Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection Journal of Neuroimmunology. 168: 154-163. PMID 16091292 DOI: 10.1016/j.jneuroim.2005.07.002  1
2005 Cysique LA, Brew BJ, Halman M, Catalan J, Sacktor N, Price RW, Brown S, Atkinson JH, Clifford DB, Simpson D, Torres G, Hall C, Power C, Marder K, McArthur JC, et al. Undetectable cerebrospinal fluid HIV RNA and beta-2 microglobulin do not indicate inactive AIDS dementia complex in highly active antiretroviral therapy-treated patients. Journal of Acquired Immune Deficiency Syndromes (1999). 39: 426-9. PMID 16010165 DOI: 10.1097/01.qai.0000165799.59322.f5  1
2005 Robertson K, Kopnisky K, Mielke J, Appiah K, Hall C, Price R, Kumwenda J, Kanyama C, Amod F, Marra C, Taylor T, Lalloo U, Jelsma J, Holding P, Boivin M, et al. Assessment of neuroAIDS in Africa. Journal of Neurovirology. 11: 7-16. PMID 15960235 DOI: 10.1080/13550280590922711  1
2005 Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW. T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection Journal of Acquired Immune Deficiency Syndromes. 39: 16-22. PMID 15851909 DOI: 10.1097/01.qai.0000155036.03004.a0  1
2005 Price RW, Robertson K. Editorial comment: Déjà Vu - Neurologic complications of HIV infection in the expanding epidemic Aids Reader. 15: 144. PMID 15786578  1
2005 Spudich SS, Huang W, Nilsson AC, Petropoulos CJ, Liegler TJ, Whitcomb JM, Price RW. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia. The Journal of Infectious Diseases. 191: 890-8. PMID 15717264 DOI: 10.1086/428095  1
2005 Gisslén M, Rosengren L, Hagberg L, Deeks SG, Price RW. Cerebrospinal fluid signs of neuronal damage after antiretroviral treatment interruption in HIV-1 infection Aids Research and Therapy. 2. DOI: 10.1186/1742-6405-2-6  1
2004 Sidenius N, Nebuloni M, Sala S, Zerbi P, Price RW, Gisslen M, Hagberg L, Vago L, Lazzarin A, Blasi F, Cinque P. Expression of the urokinase plasminogen activator and its receptor in HIV-1-associated central nervous system disease Journal of Neuroimmunology. 157: 133-139. PMID 15579290 DOI: 10.1016/j.jneuroim.2004.08.038  1
2004 Neuenburg JK, Sinclair E, Nilsson A, Kreis C, Bacchetti P, Price RW, Grant RM. HIV-producing T cells in cerebrospinal fluid Journal of Acquired Immune Deficiency Syndromes. 37: 1237-1244. PMID 15385730 DOI: 10.1097/01.qai.0000136733.09275.fa  1
2004 Kao AW, Price RW. Chemokine receptors, neural progenitor cells, and the AIDS dementia complex Journal of Infectious Diseases. 190: 211-215. PMID 15216453 DOI: 10.1086/422012  1
2004 Shacklett BL, Cox CA, Wilkens DT, Karlsson RK, Nilsson A, Nixon DF, Price RW. Increased adhesion molecule and chemokine receptor expression on CD8 + T cells trafficking to cerebrospinal fluid in HIV-1 infection Journal of Infectious Diseases. 189: 2202-2212. PMID 15181567 DOI: 10.1086/421244  1
2004 Cinque P, Nebuloni M, Santovito ML, Price RW, Gisslen M, Hagberg L, Bestetti A, Vago G, Lazzarin A, Blasi F, Sidenius N. The Urokinase Receptor Is Overexpressed in the AIDS Dementia Complex and Other Neurological Manifestations Annals of Neurology. 55: 687-694. PMID 15122709 DOI: 10.1002/ana.20076  1
2004 Valle M, Price RW, Nilsson A, Heyes M, Verotta D. CSF quinolinic acid levels are determined by local HIV infection: Cross-sectional analysis and modelling of dynamics following antiretroviral therapy Brain. 127: 1047-1060. PMID 15013955 DOI: 10.1093/brain/awh130  1
2004 Price RW, Deeks SG. Antiretroviral drug treatment interruption in human immunodeficiency virus-infected adults: Clinical and pathogenetic implications for the central nervous system Journal of Neurovirology. 10: 44-51. PMID 14982739  1
2003 Price RW. Editorial Comment: Diagnosis of Focal Brain Lesions - Old Lessons Retaught Aids Reader. 13: 553. PMID 14649626  1
2002 Neuenburg JK, Brodt HR, Herndier BG, Bickel M, Bacchetti P, Price RW, Grant RM, Schlote W. HIV-related neuropathology, 1985 to 1999: Rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes. 31: 171-177. PMID 12394795  1
1987 Navia BA, Price RW. The acquired immunodeficiency syndrome dementia complex as the presenting or sole manifestation of human immunodeficiency virus infection. Archives of Neurology. 44: 65-9. PMID 3800724 DOI: 10.1001/archneur.1987.00520130051017  1
1987 Rottenberg DA, Moeller JR, Strother SC, Sidtis JJ, Navia BA, Dhawan V, Ginos JZ, Price RW. The metabolic pathology of the AIDS dementia complex. Annals of Neurology. 22: 700-6. PMID 3501695 DOI: 10.1002/ana.410220605  1
1987 Pumarola-Sune T, Navia BA, Cordon-Cardo C, Cho ES, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Annals of Neurology. 21: 490-6. PMID 3296948 DOI: 10.1002/ana.410210513  1
1986 Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Annals of Neurology. 19: 224-38. PMID 3963767 DOI: 10.1002/ana.410190303  1
1986 Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Annals of Neurology. 19: 517-24. PMID 3729308 DOI: 10.1002/ana.410190602  1
1986 Petito CK, Cho ES, Lemann W, Navia BA, Price RW. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. Journal of Neuropathology and Experimental Neurology. 45: 635-46. PMID 3021914  1
1986 Doro S, Navia BA, Kahn A, Pumarola-Sune T, Price RW. Confirmation of HTLV-III virus in cornea. American Journal of Ophthalmology. 102: 390-1. PMID 3019144  1
1986 Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Annals of Neurology. 19: 525-35. PMID 3014994 DOI: 10.1002/ana.410190603  1
1986 Price RW, Navia BA, Cho ES. AIDS encephalopathy. Neurologic Clinics. 4: 285-301. PMID 2425241  1
1985 Jordan BD, Navia BA, Petito C, Cho ES, Price RW. Neurological syndromes complicating AIDS. Frontiers of Radiation Therapy and Oncology. 19: 82-7. PMID 3979830  1
1985 Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. The New England Journal of Medicine. 312: 874-9. PMID 3974673 DOI: 10.1056/NEJM198504043121402  1
1985 Shaw GM, Harper ME, Hahn BH, Epstein LG, Gajdusek DC, Price RW, Navia BA, Petito CK, O'Hara CJ, Groopman JE. HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science (New York, N.Y.). 227: 177-82. PMID 2981429  1
Show low-probability matches.